- Home
- ADTX vs RENX Comparison
ADTX vs RENX Comparison
Compare ADTX & RENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADTX | RENX |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 2.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADTX | RENX |
|---|---|---|
| Price | $1.11 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.2M | ★ 8.4M |
| Earning Date | 11-18-2025 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,945.00 | ★ $4,970,752.00 |
| Revenue This Year | $15,768.94 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2770.15 |
| 52 Week Low | $1.05 | $0.17 |
| 52 Week High | $6,412.72 | $3.03 |
Technical Indicators
Market Signals| Indicator | ADTX | RENX |
|---|---|---|
| Relative Strength Index (RSI) | 36.31 | N/A |
| Support Level | $1.30 | N/A |
| Resistance Level | $1.33 | N/A |
| Average True Range (ATR) | 0.44 | 0.00 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 2.22 | 0.00 |
Price Performance
Historical ComparisonAbout ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About RENX RenX Enterprises Corp. Common Stock
RenX Enterprises Corp is a real estate development and environmental solutions company. It is focused on the direct acquisition and indirect investment in properties across the United States that are intended for development into green single-family or multifamily housing projects. The company also focuses on the monetization of its real estate assets. It processes source-separated green waste and is expanding into the production of sustainable, high-margin potting media and soil substrates through advanced milling technology.